|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 156.80 EUR | -0.95% |
|
-0.06% | +31.76% |
| 08-04 | Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration | CI |
| 08-03 | Jefferies Downgrades Ipsen to Underperform, Boosts PT | MT |
EPS & Dividend: Ipsen
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 1.2 | 1.2 | 1.2 | 1.4 | 1.4 | 1.535 | 1.532 | 1.655 |
| Rate of return | 1.49% | 1.19% | 1.11% | 1.26% | 1.18% | 0.97% | 0.97% | 1.05% |
| EPS 2 | 7.76 | 7.81 | 7.73 | 4.15 | 5.32 | 12.03 | 11.39 | 11.38 |
| Distribution rate | 15.5% | 15.4% | 15.5% | 33.7% | 26.3% | 12.8% | 13.5% | 14.5% |
| Reference price 2 | 80.50 | 100.50 | 107.90 | 110.70 | 119.00 | 158.30 | 158.30 | 158.30 |
| Nbr of stocks (in thousands) | 82,243 | 82,380 | 82,599 | 82,700 | 82,100 | 81,990 | - | - |
| Announcement Date | 2/11/22 A | 2/9/23 A | 2/8/24 A | 2/13/25 A | 2/12/26 A | - | - | - |
1EUR in Million2EUR
Estimates
Past dividends: Ipsen
| 03/06/2026 | Ex-dividend date - 1.6 EUR | 07:00 |
Upcoming Events: Ipsen
| 01/10/2026 | Information meeting | Day | |
| 22/10/2026 | Sales and Revenue Release | Q3 2026 | Day |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | 0.97% | 0.97% | 13.16x | 2.54x | 2.58x | |
| 0.56% | 0.62% | 34.93x | 21.43x | 12.78x | |
| 2.05% | 2.15% | 29.12x | - | - | |
| 2.77% | 2.91% | 31.66x | 2363.42x | 7.38x | |
| 2.68% | 2.74% | 20.79x | 7.47x | 4.93x | |
| 2.79% | 2.91% | 22.24x | 6.27x | 5.75x | |
| 2.05% | 2.18% | 20.77x | 4.67x | 4.28x | |
| 2.42% | 2.55% | 26.18x | 19.73x | 6.87x | |
| 3.66% | 3.63% | 13.88x | 5.82x | 4.98x | |
| 2.48% | 2.56% | -41.32x | 8.22x | 5.92x | |
| Average | 2.24% | 2.32% | 17.14x | 271.06x | 6.16x | |
| Weighted average by Cap. | 1.94% | 2.03% | 24.95x | 349.37x | 8.30x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
